Filter
126
Filtered Results: 126
Text search:
selective
serotonin
reuptake
inhibitors
Featured
Recommendations
27
New Publications
25
Language
Document type
No document type
85
Guidelines
19
Manuals
13
Studies & Reports
6
Training Material
3
Countries / Regions
India
11
Global
3
Zambia
3
Kenya
2
Jamaica
2
South Africa
2
Uganda
2
Nepal
1
Ukraine
1
Syria
1
Canada
1
Singapore
1
Asia
1
Western and Central Europe
1
Bangladesh
1
Ethiopia
1
Libya
1
South Sudan
1
Indonesia
1
Liberia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Guidelines
11
Drugs & Medical Equipment
8
Palliative Care
6
TB
5
Paediatrics
4
Palliative Care
4
Mental Health
3
Non-communicable Diseases
3
Age & Elderly
3
Policies & Guidelines HIV & TB
2
HIV & STI
2
Communicable Diseases
1
Hepatitis
1
Diabetes
1
Humanitarian Aid
1
Cancer
1
Cancer Treatment & Resources
1
Infection Control & Prevention (IPC)
1
Public Health
1
Pediatrics
1
Training Manuals
1
Policies
1
Women & Child Health
1
Community Health
1
Information, Education and Communication (IEC)
1
Disabilities
1
Studies & Reports
1
Capacity Building
1
Communicable Diseases
1
Primary Health Care
1
Neurology & Psychology
1
Disease Prevention & Control
1
Toolboxes
Children/Adolescents Mental Disorders
23
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
19
Anxiety Disorders
12
Depression
12
Mental Disorders
11
Mental Health GAP Action Programme
11
Training Supporting Material mhGAP
8
others
8
Diagnosis & Treatment PTSD in Children
5
Neurological Disorders
5
Substance Use Disorders & Addiction
5
Bipolar Affective Disorders
5
mhGAP Guides
4
Posttraumatic stress disorder Adults
3
Essential Medicines & Devices Lists
3
Drug resistant TB
3
Alzheimer's Disease & Dementia
3
Natural Disaster
2
HIV in Children and mental health
2
Clinical Aspects
2
Children & Adolescents
2
Substance Use Disorders, Others
2
General Studies & Reports
2
Latin America
2
Children
2
IEC Material Mental Disorders
2
Clinical Guidelines
2
Gambling
2
Model Formulary
2
Rational use of Medicine
2
Clinical Aspects & Diagnosis
2
Psychosocial Support
2
War & Conflict
1
Drugs
1
Alcohol
1
Psychosocial Support (MHPSS)
1
ART Drug Resistance
1
Global Mental Health
1
Childhood TB
1
Background PTSD in children
1
Prevention & Control
1
Adults
1
Natural Disasters
1
Zambia
1
Policies & Programmes
1
Policies
1
Hepatitis
1
Treatment Guidelines HIV
1
General Mental Health Guidelines
1
HIV
1
TB
1
Mental Health
1
Health & Refugee
1
Mental Health Studies & Reports
1
Stress
1
Primary Care
1
Community Health Workers CHW
1
Essential Medicines
1
Traditional & Herbal Medicines
1
HIV &TB
1
Reports & Studies
1
Health Worker
1
Global Overview
1
Co-Morbidities (except TB)
1
Community Worker
1
Mental disorders, others
1
Modules
1
Uganda
1
HIV and coinfection
1
TB/HIV Coinfection
1
HIV service delivery
1
Community-based Mental Health Care
1
Antiretroviral Treatment ART
1
Psychosocial Support
1
Training & Capacity Building
1
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
Sci Rep. 2016; 6: 25920. Published online 2016 May 16. doi: 10.1038/srep25920
This guide covers: Treatment That Works; Myths About Treatment; Success Stories; Resources | Do you or a loved one have PTSD? There is no need to suffer. Treatment works. If you have PTSD—posttraumatic stress disorder — you don’t have to suffer. There are good treatments that can help. This b...
Abstract: Posttraumatic stress disorder (PTSD) is a chronic psychological disorder that can develop after exposure to a traumatic event. This review summarizes the literature on the epidemiology, assessment, and treatment of PTSD. We provide a review of the characteristics of PTSD along with associa...
Q4: For people with dementia with associated depression, do antidepressants when compared to placebo/comparator produce benefits/harm in the specified outcomes?
Dialogues Clin Neurosci. 2017 Jun; 19(2): 93–107.
International Journal of Psychiatry in Clinical Practice, 2012; 16: 77–84
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
Q 2: How long should treatment with antidepressants continue in adults with depressive episode/disorder?
Anxiety disorders
Chapter F.5
Q10: Are antidepressants (Tricyclic antidepressants (TCA), Selective serotonin reuptake inhibitors (SSRIs)) effective and safe in children 6-12 years of age with depressive episode/disorder?
Occasional anxiety is a normal part
of life. You might worry about things
like health, money, or family
problems. But people with
generalized anxiety disorder (GAD)
feel extremely worried or feel
nervous about these and other
things—even when there is little or
no reason to worry about the...
Do you sometimes have sudden attacks of
anxiety and overwhelming fear that last for
several minutes? Maybe your heart pounds,
you sweat, and you feel like you can’t
breathe or think. Do these attacks occur at
unpredictable times with no obvious trigger,
causing you to worry about the possibi...
Standard Treatment Guideline
As part of the Mental Health Gap Action Programme, WHO has developed training manuals (Training of trainers and supervisors training manual and Training of health-care providers training manual) to support implementation of the mhGAP Intervention Guide for mental, neurological and substance use (MNS...
WHO Model Formulary
recommended
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
(2015)
Scoping question: Are antidepressants (specifically, tricyclic antidepressants and selective serotonin reuptake inhibitors) effective and safe in adolescents with moderate-severe depressive disorder for whom psychosocial interventions have proven ineffective?
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
An Evidence-Based Treatment Guide for Clinicians
